maintenance venetoclax and 5-azacytidine in patients with aml
Published 2 years ago • 327 plays • Length 2:37Download video MP4
Download video MP3
Similar videos
-
2:27
low-dose azacitidine and venetoclax as maintenance therapy in patients with aml
-
1:50
the challenge of treating elderly patients with aml with venetoclax plus azacitidine
-
1:50
treating patients with poor-risk cytogenetics with venetoclax and hmas
-
3:03
venetoclax and 5-azacytidine for the treatment of mds and cmml
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
12:05
how to clean/change biobase hematology valves
-
6:39
treatment failure and relapse in acute myeloid leukemia (aml)
-
43:10
venetoclax plus gilteritinib for flt3-mutated relapsed/refractory acute myeloid leukemia
-
2:19
cladribine ldac venetoclax alternated with azacitidine venetoclax in older patients with aml
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
4:42
dr. willekens presents efficacy findings for reduced-dose venetoclax in aml
-
2:16
venetoclax-based salvage therapy in patients with r/r aml previously treated with targeted agents
-
3:03
outcomes following venetoclax monotherapy in patients with r/r wm in the real-world setting
-
1:40
venetoclax and azacitidine in older patients with aml
-
2:18
phase ib study of venetoclax plus azacitidine in patients with r/r mds
-
1:59
the efficacy of venetoclax-based salvage therapy in patients with previously treated r/r aml
-
1:51
rationale of omniverse: oral azacitidine venetoclax in patients with r/r or newly diagnosed aml
-
3:30
aspen-05 preliminary data: evorpacept plus azacitidine and venetoclax in patients with aml
-
1:48
azacitidine and venetoclax maintenance post allosct in high-risk t-all
-
1:40
oral combination of hmas venetoclax in unfit or elderly patients with aml
-
1:08
the importance of predicting venetoclax response in patients with aml
-
2:03
maintenance therapy in aml